Related Experiment Videos
Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease
1Department of Pharmaceutical Technology, University of Leipzig, 04207 Leipzig, Germany. leopold@compuserve.com
Drug Development and Industrial Pharmacy
|January 9, 2001
Summary
Acid-soluble coatings on colon-targeted drug delivery systems show pH-dependent drug release. Eudragit E and AEA coatings demonstrate varying drug release profiles influenced by pH and hydrodynamic stress, crucial for inflammatory bowel disease treatment.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) acute attacks cause significant colonic luminal pH decrease.
- This pH drop presents an opportunity for targeted drug delivery to the colon using acid-soluble coatings.
- Developing effective colon-specific dosage forms is key for topical IBD treatment.
Purpose of the Study:
- To evaluate the drug release characteristics of minitablets coated with acid-soluble polymers (Eudragit E, AEA).
- To investigate the influence of pH and hydrodynamic stress on drug release from these coated dosage forms.
- To assess the potential of these formulations for topical drug delivery in the colon.
Main Methods:
- Two minitablet formulations (conventional and swellable) were prepared by direct compression.
- Tablets were coated with varying amounts of Eudragit E or AEA.
- Dexamethasone release was measured spectrophotometrically across a pH range (2.0-6.8) and stirring rates (100-200 rpm).
Main Results:
- AEA coatings exhibited longer drug release lag times than Eudragit E due to slower dissolution and lower permeability.
- At low pH, drug release was stirring rate-dependent, linked to polymer film dissolution time.
- At pH 6.8, non-swelling Eudragit E tablet release was unaffected by hydrodynamic stress; AEA release depended on diffusion; swelling tablets showed no hydrodynamic stress effect.
Conclusions:
- Coating polymers like Eudragit E and AEA can modulate drug release for colon targeting.
- Formulation design (swellable vs. conventional) and coating properties significantly impact release kinetics.
- These findings support the development of pH-triggered, colon-specific drug delivery systems for IBD.